All In Biotech

Drug Trial Radar · NCT07019922

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy

Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Aug 13, 2025

Primary completion

Dec 2026

Study completion Dec 2028

Sponsor

Lead sponsor
Praxis Precision MedicinesIndustry
Sponsor type
Industry
First posted
Jun 13, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 day, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy

Conditions

  • Epileptic Encephalopathy
  • SCN2A Encephalopathy

Interventions

  • 1mg elsunersenDrug

    24 weeks every 4 weeks intrathecally

  • 0.5mg elsunersenDrug

    24 weeks every 4 weeks intrathecally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the efficacy of elsunersen on seizure frequency in participants with early-onset SCN2A DEETime frame: 24 weeks

Locations

10 sites in 4 countries. Site status is shown where the registry gives one.

  • Praxis Research Site

    San Diego, California · Recruiting

  • Praxis Research Site

    Aurora, Colorado · Recruiting

  • Praxis Research Site

    Chicago, Illinois · Recruiting

  • Praxis Research Site

    Cincinnati, Ohio · Recruiting

  • Praxis Research Site

    Philadelphia, Pennsylvania · Recruiting

  • Praxis Research Site

    Memphis, Tennessee · Recruiting

  • Praxis Research Site

    Porto Alegre, Brazil · Withdrawn

  • Praxis Research Site

    São Paulo, Brazil · Withdrawn

  • Praxis Research Site

    Bonn, Bonn, Germany · Recruiting

  • Praxis Research Site

    Rome, Italy · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.